CRP and cardiovascular disorder: The results of the current study reported median CRP levels in OCP users (~2 mg L−1) and naturally menstruating females (~0.4 mg L−1), with one naturally menstruating female considered to have an intermediate risk of cardiovascular disease and the remaining (n = 7) presenting with CRP levels <1 mg L−1.